Brief: Design Therapeutics posts Q1 basic EPS USD -0.35
09/05/2023 23:03
May 9 (Reuters) - Design Therapeutics Q1 operating income USD -21.651 million. * Q1 net income USD -19.294 million * Q1 basic EPS USD -0.35 * Q1 operating expenses USD 21.651 million
Recent news on Design Therapeutics
See all newsDesign Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Design Therapeutics Q2 net loss narrower than expected
Brief: Design Therapeutics Q2 Basic EPS USD -0.32
Design Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Design Therapeutics Announces Initiation Of Patient Dosing In Phase 1 Multiple Ascending Dose Trial Of Dt-818 For Myotonic Dystrophy Type-1